Immunic (IMUX) Short-term Investments (2022 - 2023)
Immunic's (IMUX) quarterly Short-term Investments came in at $4.4 million in Q1 2023, down 54.3% quarter-over-quarter from $9.6 million in Q4 2022.
Immunic (IMUX) Short-term Investments (2022 - 2023) Analysis & Trends
Immunic has disclosed Short-term Investments across 2 years of filings, most recently posting $4.4 million for Q1 2023.
- Short-term Investments for Q1 2023 came in at $4.4 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2023 was $4.4 million (changed N/A YoY), and the FY2022 annual result was $9.6 million, changed N/A from the prior year.
- Short-term Investments came in at $4.4 million for Q1 2023 at Immunic, down from $9.6 million in the prior quarter.
- In the past five years, Short-term Investments ranged from a high of $9.6 million in Q4 2022 to a low of $4.4 million in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - |
| 10 | Immunic | 384.84 Mn | 198.21 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 4.40 Mn |
| Dec 31, 2022 | 9.63 Mn |